Sign in
NNNN Stock Price, Chart, Stats & News
Anbio Biotechnology Class A Ordinary Shares
Save
Anbio Biotechnology Class A Ordinary Shares (NNNN) does not currently pay a dividend.
276.51M
Market cap
38.49x
Current P/E
–
Forward P/E
NNNN chart
Fundamentals
Gross margin | 89.72% |
Operating margin | 25.78% |
Pretax margin | 37.47% |
Net margin | 37.47% |
Effective tax rate | – |
ROA | 8.69% |
ROE | 11.40% |
D/E | – |
Interest coverage ratio | – |
NNNN valuation
P/E | 38.49x |
P/S | 139.32x |
P/B | 32.46x |
P/CF | 654.34x |
P/FCF | 654.34x |
P/OCF | 654.34x |
PEG | 86.67x |
EV multiple | 374.09x |
About
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B).
Similar securities
Based on sector and market capitalization
Report issue